Biotech giants and AI firms lobby for DNA data governance as genomic surveillance expands globally
Original framing: “STAT+: AI titans push Congress for DNA safeguards” — STAT News
The history of eugenics—from 19th-century craniometry to 20th-century sterilization programs—shows how 'scientific' claims about genetic inferiority have been weaponized to justify oppression. The Human Genome Project (1990–2003) initially excluded non-European populations, reinforcing a bias that persists in modern AI-driven genomics. Colonial-era anthropometry, which measured skulls to 'prove' racial hierarchies, laid the groundwork for today’s genomic surveillance, where algorithms inherit these biases.
The push for 'DNA safeguards' by AI and biotech titans is less about protecting the public than about preempting regulation that might threaten their monopolies on genomic data—a resource extracted from marginalised bodies and repackaged as 'innovation.
' This dynamic mirrors historical patterns of colonial extraction, from blood samples in the Congo to the patenting of turmeric by Western firms, revealing a throughline of bio-colonialism. Yet Indigenous and Global South communities are not passive victims; they are actively resisting through frameworks like genomic sovereignty and benefit-sharing agreements, while artists and scientists expose the absurdity of treating DNA as a commodity. The solution lies not in corporate-led 'safeguards' but in a global shift toward decolonial genomics, where data is governed by those it represents, not those who profit from it. This requires dismantling the bio-surveillance industrial complex, auditing algorithms for bias, and redirecting capital toward community-controlled biotech—all while acknowledging that the future of genomics must be plural, not proprietary.